Cited by 7Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional DevelopmentSubstance Abuse Treatment and Outcomes

A Pilot Study of Stimulant Medication for Adults with Attention-Deficit/Hyperactivity Disorder (ADHD) Who Are Parents of Adolescents with ADHD: The Acute Effects of Stimulant Medication on Observed Parent–Adolescent Interactions

Open access
Babinski, Dara E., Waxmonsky, James G., Waschbusch, Daniel A., Humphrey, Hugh, Alfonso, Alexandra, Crum, Kathleen I., Bernstein, Melissa, Slavec, Janine +2 more·2014·Journal of Child and Adolescent Psychopharmacology

Abstract

OBJECTIVE: This study explores the use of stimulant medication for parents with attention-deficit/hyperactivity disorder (ADHD) who also have adolescents with ADHD. METHODS: Five parents, diagnosed with ADHD, had their dose of lisdexamfetamine (LDX) titrated to optimal effect. Next, parents and their adolescents completed two interactions, once when parents were on placebo and once when parents were on optimal dose of LDX, to assess acute effects of parental medication on parenting during a neutral discussion (NeuDiss), a problem discussion (ProbDiss), and a homework task (HW). RESULTS: Parents demonstrated a significant decrease in the ratio of commands to total verbalizations during the NeuDiss on LDX compared with placebo. Although no other statistically significant effects emerged at the p<0.05 level, moderate to large effects of medication on some aspects of parenting related to the amount and timing of speech (i.e., total verbalizations, total commands, ratio of commands to total verbalizations, and responsiveness) emerged and varied by task. Parental stimulant medication did not appear to impact the content of parents' speech (i.e., use of negative talk or praise). CONCLUSIONS: These results add to a growing literature suggesting that treatment for parental ADHD may impact parenting performance, and suggest that attention to parental ADHD in treatment for adolescents with ADHD may possibly enhance family functioning.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/cap.2014.0092

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In another post hoc analysis of the AWE study, mean BADDS total score decreased from 74.3 at baseline to 40.9 at dose-optimization week 4 for all LDX doses (P < .0001), and optimal response was observed in 67% based on BADDS at week 4.

    “Likewise, another post hoc analysis of the AWE study noted the mean BADDS total score from baseline to dose-optimization week 4 decreased from 74.3 to 40.9 for all LDX doses (P < .0001), and the optimal response was observed in 67% of the patients based on BADDS scores at week 4.”

    From Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder (2017) · cites this paper as [42]

    The Methods describe a three-week LDX trial in eight parents of adolescents, with ADHD-RS and CGI assessments; the Results report observed parent–adolescent interactions. Searches for BADDS scores and the AWE week-4 analysis found no passage reporting the claimed scores, P value, or 67% response rate. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 17

  1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994 [Google Scholar]
  2. Barkley RA: Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. Guildford Press: New York; 2006 [Google Scholar]
  3. Chronis-Tuscano AM, Seymour KE, Stein MA, Jones HA, Roomey ME, Conlon C, Efron LA, Wagner SA, Pian J, Robb AS: Efficacy of OROS methylphenidate for mothers with ADHD: Preliminary effects on ADHD symptoms and parenting. J Clin Psychiatry 69:1938–1947, 2008 [DOI] [PubMed] [Google Scholar]
  4. Dishion TJ, Nelson SE, Bullock BM: Premature adolescent autonomy: Parent disengagement and deviant peer processes in the amplification of problem behavior. J Adolesc 27:515–530, 2004 [DOI] [PubMed] [Google Scholar]
  5. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R: ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation. New York: Guilford Press; 1998 [Google Scholar]
  6. Edwards G, Barkley RA, Laneri M, Fletcher K, Metevia L: Parent–adolescent conflict in teenagers with ADHD and ODD. J Abnorm Child Psychol 29:557–572, 2001 [DOI] [PubMed] [Google Scholar]
  7. Evans SW, Vallano G, Pelham WE: Treatment of parenting behavior with psychostimulant: A case study of an adult with attention-deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 4:63–39, 1994 [Google Scholar]
  8. Johnston C, Mash EJ, Miller N, Ninowski JE: Parenting in adults with attention-deficit/hyperactivity disorder. Clin Psychol Rev 32:215–228, 2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Molina BSG, Pelham WE: Attention-deficit/hyperactivity disorder and risk for substance use disorder: Developmental considerations, potential pathways, and opportunities for research. Annu Rev Clin Psychol 10:607–639, 2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Patterson GR, Forgatch MS: Parents and Adolescents Living Together. Part 1: The Basics, 2nd ed. Champaign, IL: Research Press; 2005 [Google Scholar]
  11. Pelham WE, Gnagy EM, Greenslade KE, Milich R: Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders. J Am Acad Child Adolesc Psychiatry 31:210–218, 1992 [DOI] [PubMed] [Google Scholar]
  12. Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab–Stone ME: NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): Description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry 39:28–38, 2000 [DOI] [PubMed] [Google Scholar]
  13. Sheehan DV, Harnett-Sheehan K, Raj BA: The measurement of disability. Int Clin Psychopharmacol 11:89–95, 1996 [DOI] [PubMed] [Google Scholar]
  14. Sibley MH, Kuriyan AB, Evans SW, Waxmonsky JG, Smith BH: Pharmacological and psychosocial treatments for adolescents with ADHD: An updated systematic review of the literature. Clin Psychol Rev 34:218–232, 2014 [DOI] [PubMed] [Google Scholar]
  15. Waxmonsky JG, Waschbusch DA, Babinski DE, Humphrey H, Alfonso A, Crum KI, Bernstein M, Slavec J, Augustus JN, Pelham WE: Does pharmacological treatment of ADHD in adults enhance parenting performance? Results of a double-blind randomized trial. CNS Drugs 28:665–677, 2014 [DOI] [PubMed] [Google Scholar]
  16. Wechsler D. Wechsler Individual Achievement Test – Second Edition. San Antonio: Harcourt; 2002 [Google Scholar]
  17. Wechsler D: Wechsler Intelligence Scale for Children – Fourth Edition. San Antonio: The Psychological Corportation; 2005 [Google Scholar]

Cited by

Sorted by citations

Authors
Babinski, D. E., Waxmonsky, J. G., Waschbusch, D. A., Humphrey, H., Alfonso, A., Crum, K. I., Bernstein, M., Slavec, J., Augustus, J. N., & Pelham, W. E.
Affiliations
Florida International University (US)
Corresponding author
Babinski, Dara E.
Venue
Journal of Child and Adolescent Psychopharmacology
Published
2014-12
Volume
24
Issue
10
Pages
582-585
ISSN
  • 1044-5463 (ISSN-L)
  • 1557-8992
OpenAlex
W1458465024
Cited by
7
References
2
Citations by year
2020: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 1
FWCI
1.27
Type
journal article
Language
en
Open access
Locations
  • Journal of Child and Adolescent Psychopharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Shire
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
parental ADHD, stimulant medication, lisdexamfetamine, parenting, parent-adolescent interaction, family functioning, parental responsiveness
MeSH terms
Lisdexamfetamine Dimesylate, Adolescent, Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Dextroamphetamine, Female, Humans, Male, Middle Aged, Parent-Child Relations, Pilot Projects, Parenting

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review